Voclosporin: Completed Phase IIb enrollment

Aurinia completed enrollment of 265 patients in the double-blind, placebo-controlled, international Phase IIb AURA-LV trial evaluating 23.7 and 39.5 mg oral voclosporin twice daily with mycophenolate mofetil (MMF) and oral corticosteroids. Patients in the high-dose arm will receive the low dose until week 2. ...